LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.66 USD -2.35% Market Closed
Market Cap: 43.6m USD
Have any thoughts about
LAVA Therapeutics NV?
Write Note

Gross Margin
LAVA Therapeutics NV

97.8%
Current
21%
Average
63.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
97.8%
=
Gross Profit
7.2m
/
Revenue
7.4m

Gross Margin Across Competitors

Country NL
Market Cap 43.7m USD
Gross Margin
98%
Country FR
Market Cap 6T USD
Gross Margin
0%
Country US
Market Cap 299.8B USD
Gross Margin
67%
Country US
Market Cap 159.1B USD
Gross Margin
60%
Country US
Market Cap 124.7B USD
Gross Margin
86%
Country US
Market Cap 114.8B USD
Gross Margin
78%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 137.3B AUD
Gross Margin
52%
Country US
Market Cap 86.2B USD
Gross Margin
87%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country NL
Market Cap 34B EUR
Gross Margin
89%

Profitability Report

View the profitability report to see the full profitability analysis for LAVA Therapeutics NV.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
97.8%
=
Gross Profit
7.2m
/
Revenue
7.4m
What is the Gross Margin of LAVA Therapeutics NV?

Based on LAVA Therapeutics NV's most recent financial statements, the company has Gross Margin of 97.8%.